The TB structural genomics consortium: providing a structural foundation for drug discovery.
Curr Drug Targets Infect Disord
; 2(2): 121-41, 2002 Jun.
Article
em En
| MEDLINE
| ID: mdl-12462144
ABSTRACT
Structural genomics, the large-scale determination of protein structures, promises to provide a broad structural foundation for drug discovery. The tuberculosis (TB) Structural Genomics Consortium is devoted to encouraging, coordinating, and facilitating the determination of structures of proteins from Mycobacterium tuberculosis and hopes to determine 400 TB protein structures over 5 years. The Consortium has determined structures of 28 proteins from TB to date. These protein structures are already providing a basis for drug discovery efforts.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Proteínas de Bactérias
/
Aciltransferases
/
Desenho de Fármacos
/
Genômica
/
Antibacterianos
/
Mycobacterium tuberculosis
/
Antígenos de Bactérias
Idioma:
En
Revista:
Curr Drug Targets Infect Disord
Assunto da revista:
DOENCAS TRANSMISSIVEIS
/
TERAPIA POR MEDICAMENTOS
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Estados Unidos